InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (17 ops.)
Insider track record
Board DirectorDisclosed buys
6
Disclosed sells
17
T+90 hit rate
100%
T+90 mean return
+61.6%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Thompson Peter A., Director. Insider active across 7 companies, notably Janux Therapeutics, Inc.. Cumulatively, 29 disclosures have been published. Split: 6 buys · 17 sells. Total volume traded: €77.8m. History available since 17 September 2021. The latest transaction was disclosed on 7 July 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Thompson Peter A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations29 total
85,918 shares@ US$44.860.19% mcap13.5% of flowCommon StockSEC:0000947871-26-000695:0
52,397 shares@ US$44.680.11% mcap9.2% of flowCommon StockSEC:0000947871-26-000459:0
2,948 shares@ US$44.520.0063% mcap0.5% of flowCommon StockSEC:0000947871-26-000459:1
47,814 shares@ US$44.510.10% mcap8.4% of flowCommon StockSEC:0000947871-26-000447:0
235,863 shares@ US$44.640.50% mcap41.4% of flowCommon StockSEC:0000947871-26-000447:1
226,906 shares@ US$45.340.49% mcap40.5% of flowCommon StockSEC:0000947871-26-000447:2
1,890 shares@ US$44.570.2% of flowCommon StockSEC:0000947871-26-000089:0
30,000 shares@ US$15.003.6% of flowCommon StockSEC:0000947871-26-000079:0
33,356 shares@ US$44.554.2% of flowCommon StockSEC:0000947871-25-001095:0
900 shares@ US$44.500.1% of flowCommon StockSEC:0000947871-25-001087:0
94,583 shares@ US$44.5412.8% of flowCommon StockSEC:0000947871-25-001044:0
1,397,684 shares@ US$3.5042.1% of flowCommon StockSEC:0000947871-25-000635:0
372,578 shares@ US$20.1339.2% of flowCommon StockSEC:0000947871-25-000360:0
Canonical exit: 2 Jul 2025 (T+90)
3,154,959 sharesCommon StockSEC:0000950170-25-017031:0
83,695 shares@ US$13.0011.3% of flowCommon StockSEC:0000947871-24-000729:0
394,400 shares@ US$13.5255.5% of flowCommon StockSEC:0000947871-24-000721:0
2,416,181 sharesCommon StockSEC:0001626199-24-000096:0
454,545 shares@ US$11.0026.5% of flowCommon StockSEC:0000947871-24-000070:0
Canonical exit: 22 Apr 2024 (T+90)
145,251 shares@ US$12.7436.5% of flowCommon StockSEC:0000947871-24-000033:0
162,576 shares@ US$19.9663.5% of flowCommon StockSEC:0000947871-23-001190:0
500,000 shares@ US$6.2033.1% of flowCommon StockSEC:0000947871-23-000914:0
Canonical exit: 27 Nov 2023 (T+90)
484,496 shares@ US$10.3228.9% of flowCommon StockSEC:0000947871-22-000973:0
Canonical exit: 15 Dec 2022 (T+90)
138,000 shares@ US$7.210.036% mcap100.0% of flowCommon StockSEC:0000947871-22-000628:0
Canonical exit: 16 Aug 2022 (T+90)
36,700 shares@ US$20.307.7% of flowCommon StockSEC:0000947871-21-001322:0
108,300 shares@ US$19.0021.4% of flowCommon StockSEC:0000947871-21-001314:0
25 of 29 declarations
About Thompson Peter A.
Thompson Peter A. is Administrateur and has filed 29 reports in total. Across the 29 sampled filings, the reported volumes are EUR 24,868,571 of buys and EUR 52,905,880 of sells, over the period from 2021-06-16 to 2026-07-09. The most recent and largest transactions in this sample involve Sionna Therapeutics, Inc., Edgewise Therapeutics, Inc., Janux Therapeutics, Inc. and Corvus Pharmaceuticals, Inc.
